FDA staff urges new caution on Roche flu drug (Reuters)
13th Nov 2006, 20:29 GMT
Reuters - U.S. Food and Drug Administration staff have recommended adding a new precaution to the label of Roche AG's flu-fighting drug Tamiflu about reports of psychiatric problems in patients who take it, according to documents made public on Monday.
FDA staff urges new caution on Roche flu drug (Reuters) related news:
- FDA staff urges new caution on Roche flu drug — Reuters: Health
- Roche flu drug to carry new caution in U.S. — Reuters: Health
- FDA Urges Caution on Flu Drug — WSJ.com: What's News US
- FDA Orders Caution Over the use of Tamiflu — NPR Topics: Nation
- Tamiflu label will carry new caution in U.S. — Medical and health information and tools from Armenian Medical Network
- FDA Suggests New Tamiflu Warning — WSJ.com: What's News US
- Flu Drug Label Will Warn of Risks, FDA Says — washingtonpost.com - A Section
- FDA urges monitoring of Tamiflu patients — Boston Globe -- National News
- Tamiflu label gets 'abnormal behavior' warning — baltimoresun.com - nation/world
- FDA Posts New Tamiflu Warning — WebMD Health Headlines
Latest news from Yahoo! News: Top Stories:
- U.S. eyes China's naval power on high-level visit (Reuters)
- KB Home CEO Bruce Karatz leaving firm (AP)
- S.Korea says won't join North arms watch plan (Reuters)
- At least 20 feared dead in SAfrican train accident (Reuters)
- Bush to meet with Iraq panels as Democrats urge withdrawal (AFP)
- Oct. budget deficit higher than last yr. (AP)
- Al Qaeda seeking nuclear kit for attacks: UK official (Reuters)
- Lebanon crisis deepens, cabinet backs Hariri court (Reuters)
- Castro unlikely to re-emerge as robust self: U.S. (Reuters)
- Ten die on Baghdad bus as Iraq mulls new cabinet (AFP)